R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022)
M.F. Festari, V. da Costa, S.A. Rodríguez-Zraquia, M. Costa, M. Landeira, P. Lores, P. Solari-Saquieres, M.G. Kramer, T. Freire, The tumor-associated Tn antigen fosters lung metastasis and recruitment of regulatory T cells in triple negative breast cancer. Glycobiology 32, 366–379 (2022)
A.W. Lambert, D.R. Pattabiraman, R.A. Weinberg, Emerging biological principles of metastasis. Cell 168, 670–691 (2017)
J. Roche, Erratum: Roche J. The epithelial-to-mesenchymal transition in cancer. Cancers 10, 79 (2018)
R.M. Barnes, A.B. Firulli, A twist of insight - the role of Twist-family bHLH factors in development. Int. J. Dev. Biol. 53, 909–924 (2009)
Z. Zhao, M.A. Rahman, Z.G. Chen, D.M. Shin, Multiple biological functions of Twist1 in various cancers. Oncotarget 8, 20380–20393 (2017)
R. Kalluri, E.G. Neilson, Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776–1784 (2003)
Q.-Q. Zhu, C. Ma, Q. Wang, Y. Song, T. Lv, The role of TWIST1 in epithelial-mesenchymal transition and cancers. Tumour Biol. 37, 185–197 (2016)
B.A. Firulli, D. Krawchuk, V.E. Centonze, N. Vargesson, D.M. Virshup, S.J. Conway, P. Cserjesi, E. Laufer, A.B. Firulli, Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities. Nat. Genet. 37, 373–381 (2005)
A. Vichalkovski, E. Gresko, D. Hess, D.F. Restuccia, B.A. Hemmings, PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage. Oncogene 29, 3554–3565 (2010)
C.-W. Li, W. Xia, S.-O. Lim, J.L. Hsu, L. Huo, Y. Wu, L.-Y. Li, C.-C. Lai, S.-S. Chang, Y.-H. Hsu, H.-L. Sun, J. Kim, H. Yamaguchi, D.-F. Lee, H. Wang, Y. Wang, C.-K. Chou, J.-M. Hsu, Y.-J. Lai, A.M. LaBaff, Q. Ding, H.-W. Ko, F.-J. Tsai, C.-H. Tsai, G.N. Hortobagyi, M.-C. Hung, AKT1 inhibits epithelial-to-mesenchymal transition in breast cancer through phosphorylation-dependent Twist1 degradation. Cancer Res. 76, 1451–1462 (2016)
J. Hong, J. Zhou, J. Fu, T. He, J. Qin, L. Wang, L. Liao, J. Xu, Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 71, 3980–3990 (2011)
Y.-W. Su, T.-X. Xie, D. Sano, J.N. Myers, IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2. PLoS ONE 6, 19412 (2011)
J. Shi, Y. Wang, L. Zeng, Y. Wu, J. Deng, Q. Zhang, Y. Lin, J. Li, T. Kang, M. Tao, E. Rusinova, G. Zhang, C. Wang, H. Zhu, J. Yao, Y.-X. Zeng, B.M. Evers, M.-M. Zhou, B.P. Zhou, Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer. Cancer Cell 25, 210–225 (2014)
R.P. Gajula, S.T. Chettiar, R.D. Williams, S. Thiyagarajan, Y. Kato, K. Aziz, R. Wang, N. Gandhi, A.T. Wild, F. Vesuna, J. Ma, T. Salih, J. Cades, E. Fertig, S. Biswal, T.F. Burns, C.H. Chung, C.M. Rudin, J.M. Herman, R.K. Hales, V. Raman, S.S. An, P.T. Tran, The twist box domain is required for Twist1-induced prostate cancer metastasis. Mol. Cancer Res. 11, 1387–1400 (2013)
J. Zhong, K. Ogura, Z. Wang, H. Inuzuka, Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis. Discov. Med. 15, 7–15 (2013)
R. Lander, K. Nordin, C. LaBonne, The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1. J. Cell. Biol. 194, 17–25 (2011)
H.-J. Lee, C.-F. Li, D. Ruan, S. Powers, P.A. Thompson, M.A. Frohman, C.-H. Chan, The DNA damage transducer RNF8 facilitates cancer chemoresistance and progression through Twist activation. Mol. Cell 63, 1021–1033 (2016)
H. Chen, L. Hu, Z. Luo, J. Zhang, C. Zhang, B. Qiu, L. Dong, Y. Tan, J. Ding, S. Tang, F. Shen, Z. Li, H. Wang, A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression. Mol. Cancer 14, 186 (2015)
Y. Zhu, C. Qu, X. Hong, Y. Jia, M. Lin, Y. Luo, F. Lin, X. Xie, X. Xie, J. Huang, Q. Wu, X. Qiu, D. Piao, Y. Xing, T. Yu, Y. Lu, Q. Huang, C. Yu, J. Jin, Z. Zhang, Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ. 26, 306–320 (2019)
Y. Lin, Y. Wang, Q. Shi, Q. Yu, C. Liu, J. Feng, J. Deng, B.M. Evers, B.P. Zhou, Y. Wu, Stabilization of the transcription factors slug and twist by the deubiquitinase dub3 is a key requirement for tumor metastasis. Oncotarget 8, 75127–75140 (2017)
L. Qiang, B. Zhao, M. Ming, N. Wang, T.-C. He, S. Hwang, A. Thorburn, Y.-Y. He, Regulation of cell proliferation and migration by p62 through stabilization of Twist1. PNAS 111, 9241–9246 (2014)
F.E. Reyes-Turcu, J.R. Horton, J.E. Mullally, A. Heroux, X. Cheng, K.D. Wilkinson, The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 124, 1197–1208 (2006)
J. Liu, H. Xia, M. Kim, L. Xu, Y. Li, L. Zhang, Y. Cai, H.V. Norberg, T. Zhang, T. Furuya, M. Jin, Z. Zhu, H. Wang, J. Yu, Y. Li, Y. Hao, A. Choi, H. Ke, D. Ma, J. Yuan, Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 147, 223–234 (2011)
J. Zhang, P. Zhang, Y. Wei, H.-L. Piao, W. Wang, S. Maddika, M. Wang, D. Chen, Y. Sun, M.-C. Hung, J. Chen, L. Ma, Deubiquitylation and stabilization of PTEN by USP13. Nat. Cell. Biol. 15, 1486–1494 (2013)
X. Man, C. Piao, X. Lin, C. Kong, X. Cui, Y. Jiang, USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. J. Exp. Clin. Cancer Res. 38, 259 (2019)
Z. Qu, R. Zhang, M. Su, W. Liu, USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma. Cancer Manag. Res. 11, 9175–9183 (2019)
S. Xiang, J. Fang, S. Wang, B. Deng, L. Zhu, MicroRNA-135b regulates the stability of PTEN and promotes glycolysis by targeting USP13 in human colorectal cancers. Oncol. Rep. 33, 1342–1348 (2015)
J. Kwon, H. Choi, A.D. Ware, B.C. Morillo, H. Wang, K.B. Bouker, X. Lu, T. Waldman, C. Han, USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model. Oncogene 41, 1974–1985 (2022)
J. Huang, Z. Ye, J. Wang, Q. Chen, D. Huang, H. Liu, USP13 mediates PTEN to ameliorate osteoarthritis by restraining oxidative stress, apoptosis and inflammation via AKT-dependent manner. Biomed. Pharmacother. 133, 111089 (2021)
J. Geng, X. Huang, Y. Li, X. Xu, S. Li, D. Jiang, J. Liang, D. Jiang, C. Wang, H. Dai, Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis. Respir. Res. 16, 124 (2015)
X. Zhao, B. Fiske, A. Kawakami, J. Li, D.E. Fisher, Regulation of MITF stability by the USP13 deubiquitinase. Nat. Commun. 2, 414 (2011)
X. Fang, W. Zhou, Q. Wu, Z. Huang, Y. Shi, K. Yang, C. Chen, Q. Xie, S.C. Mack, X. Wang, A.M. Carcaboso, A.E. Sloan, G. Ouyang, R.E. McLendon, X.-W. Bian, J.N. Rich, S. Bao, Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination. J. Exp. Med. 214, 245–267 (2017)
H. Sun, Q. Zhang, Y.-Y. Jing, M. Zhang, H.-Y. Wang, Z. Cai, T. Liuyu, Z.-D. Zhang, T.-C. Xiong, Y. Wu, Q.-Y. Zhu, J. Yao, H.-B. Shu, D. Lin, B. Zhong, USP13 negatively regulates antiviral responses by deubiquitinating STING. Nat. Commun. 8, 15534 (2017)
Y. Li, K. Luo, Y. Yin, C. Wu, M. Deng, L. Li, Y. Chen, S. Nowsheen, Z. Lou, J. Yuan, USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response. Nat. Commun. 8, 15752 (2017)
Z. Jia, M. Wang, S. Li, X. Li, X.-Y. Bai, Z. Xu, Y. Yang, B. Li, Y. Li, H. Wu, U-box ubiquitin ligase PPIL2 suppresses breast cancer invasion and metastasis by altering cell morphology and promoting SNAI1 ubiquitination and degradation. Cell Death Dis. 9, 63 (2018)
Z. Xu, Y. Yang, B. Li, Y. Li, K. Xia, Y. Yang, X. Li, M. Wang, S. Li, H. Wu, Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1. Cell Death Dis. 9, 559 (2018)
F. Zhao, M. Wang, S. Li, X. Bai, H. Bi, Y. Liu, X. Ao, Z. Jia, H. Wu, DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis. Oncogenesis 4, 143 (2015)
H. Bi, S. Li, X. Qu, M. Wang, X. Bai, Z. Xu, X. Ao, Z. Jia, X. Jiang, Y. Yang, H. Wu, DEC1 regulates breast cancer cell proliferation by stabilizing cyclin E protein and delays the progression of cell cycle S phase. Cell Death Dis. 6, 1891 (2015)
T.D. Schmittgen, K.J. Livak, Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101–1108 (2008)
D.S. Chandrashekar, B. Bashel, S.A.H. Balasubramanya, C.J. Creighton, I. Ponce-Rodriguez, B.V.S.K. Chakravarthi, S. Varambally, UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649–658 (2017)
M.T. Terry, M.G. Patricia, Modeling survival data: Extending the Cox model (Springer, New York, 2000)
K. Alboukadel, K. Marcin, B. Przemyslaw, Survminer: Drawing survival curves using 'ggplot2'. R package version 0.4.9. (2021)
留言 (0)